Linnaeus Therapeutics, Inc.

📍 Haddonfield, United States🗓 Founded 2016👥 6 employees💰 Last funded Aug 2018
Biotechnology Research🌐 linnaeustx.com
Website LinkedIn
Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors. The company was formed and launched in partnership with the UPstart incubator at the University of Pennsylvania’s Penn Center for Innovation (PCI).
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Linnaeus Therapeutics, Inc.?
Linnaeus Therapeutics, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Linnaeus Therapeutics, Inc. last raise funding?
The most recent investment in Linnaeus Therapeutics, Inc. recorded on gritt.io was in August 2018.
When was Linnaeus Therapeutics, Inc. founded?
Linnaeus Therapeutics, Inc. was founded in 2016.
What industry is Linnaeus Therapeutics, Inc. in?
Linnaeus Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Linnaeus Therapeutics, Inc. based?
Linnaeus Therapeutics, Inc. is headquartered in Haddonfield, United States.